The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
ANCA Glomerulonephritis and Vasculitis
Open accessAbstract
ANCA vasculitis has an associated autoimmune response that produces ANCAs that induce distinct pathologic lesions. Pauci-immune necrotizing and crescentic GN is a frequent component of ANCA vasculitis. ANCA vasculitis is associated with ANCA specific for myeloperoxidase (MPO-ANCA) or proteinase 3 (PR3-ANCA). A diagnosis of ANCA vasculitis should always specify the serotype as MPO-ANCA positive, PR3-ANCA positive, or ANCA-negative. To fully characterize a patient, the serotype also should be accompanied by the clinicopathologic variant if this can be determined: microscopic polyangiitis, granulomatosis with polyangiitis (Wegener), eosinophilic granulomatosis with polyangiitis (Churg–Strauss), or renal-limited vasculitis. ANCA vasculitis is most prevalent in individuals >50 years old. There are racial/ethnic and geographic influences on the prevalence, serotype frequencies, and clinicopathologic phenotypes. There is clinical, in vitro, and animal model evidence that ANCAs cause disease by activating neutrophils to attack small vessels. Immunomodulatory and immunosuppressive therapies are used to induce remission, maintain remission, and treat relapses. Over recent years, there have been major advances in optimizing treatment by minimizing toxic therapy and utilizing more targeted therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Jennette, J. C., Falk, R. J., Bacon, P. A., Basu, N., Cid, M. C., Ferrario, F., Flores‐Suarez, L. F., Gross, W. L., Guillevin, L., Hagen, E. C., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37715 · Cited by 6,631
Self-citationRituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
Stone, J. H., Merkel, P. A., Spiera, R., Seo, P., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St. Clair, E. W., Turkiewicz, A., Tchao, N. K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909905 · Cited by 2,762
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
Jones, R. B., Cohen Tervaert, J. W., Hauser, T., Luqmani, R., Morgan, M. D., Peh, C. A., Savage, C. O., Segelmark, M., Tesar, V., van Paassen, P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909169 · Cited by 1,748
Watts, R., Lane, S., Hanslik, T., Hauser, T., Hellmich, B., Koldingsnes, W., Mahr, A., Segelmark, M., Cohen-Tervaert, J. W., & Scott, D. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.054593 · Cited by 1,359
Jayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Tervaert, J. W. C., Dadoniené, J., Ekstrand, A., Gaskin, G., Gregorini, G., de Groot, K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020286 · Cited by 1,348
Jayne, D. R. W., Gaskin, G., Rasmussen, N., Abramowicz, D., Ferrario, F., Guillevin, L., Mirapeix, E., Savage, C. O. S., Sinico, R. A., Stegeman, C. A., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010090 · Cited by 1,125
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
Guillevin, L., Pagnoux, C., Karras, A., Khouatra, C., Aumaître, O., Cohen, P., Maurier, F., Decaux, O., Ninet, J., Gobert, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404231 · Cited by 1,090
Genetically Distinct Subsets within ANCA-Associated Vasculitis
Lyons, P. A., Rayner, T. F., Trivedi, S., Holle, J. U., Watts, R. A., Jayne, D. R. W., Baslund, B., Brenchley, P., Bruchfeld, A., Chaudhry, A. N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108735 · Cited by 1,010
Xiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., Maeda, N., Falk, R. J., & Jennette, J. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15918 · Cited by 1,005
Self-citationde Groot, K., Harper, L., Jayne, D. R. W., Flores Suarez, L. F., Gregorini, G., Gross, W. L., Luqmani, R., Pusey, C. D., Rasmussen, N., Sinico, R. A., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-10-200905190-00004 · Cited by 957
Kitching, A. R., Anders, H.-J., Basu, N., Brouwer, E., Gordon, J., Jayne, D. R., Kullman, J., Lyons, P. A., Merkel, P. A., Savage, C. O. S., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0204-y · Cited by 928
Xiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., Maeda, N., Falk, R. J., & Jennette, J. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215918 · Cited by 919
Self-citationHistopathologic Classification of ANCA-Associated Glomerulonephritis
Berden, A. E., Ferrario, F., Hagen, E. C., Jayne, D. R., Jennette, J. C., Joh, K., Neumann, I., Noël, L.-H., Pusey, C. D., Waldherr, R., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050477 · Cited by 917
Self-citationHiemstra, T. F., Walsh, M., Mahr, A., Savage, C. O., de Groot, K., Harper, L., Hauser, T., Neumann, I., Tesar, V., Wissing, K.-M., et al. (2010) · JAMA · doi:10.1001/jama.2010.1658 · Cited by 596
Xiao, H., Schreiber, A., Heeringa, P., Falk, R. J., & Jennette, J. C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060573 · Cited by 579
Self-citationHarper, L., Morgan, M. D., Walsh, M., Hoglund, P., Westman, K., Flossmann, O., Tesar, V., Vanhille, P., Groot, K. D., Luqmani, R., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200477 · Cited by 432
Lionaki, S., Blyth, E. R., Hogan, S. L., Hu, Y., Senior, B. A., Jennette, C. E., Nachman, P. H., Jennette, J. C., & Falk, R. J. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34562 · Cited by 424
Self-citationPendergraft, W. F., Preston, G. A., Shah, R. R., Tropsha, A., Carter, C. W., Jennette, J. C., & Falk, R. J. (2004) · Nature Medicine · doi:10.1038/nm968 · Cited by 379
Self-citationPlasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis
Klemmer, P. J., Chalermskulrat, W., Reif, M. S., Hogan, S. L., Henke, D. C., & Falk, R. J. (2003) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.08.015 · Cited by 360
Clinical features and outcome of patients with both ANCA and anti-GBM antibodies
Levy, J. B., Hammad, T., Coulthart, A., Dougan, T., & Pusey, C. D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00917.x · Cited by 357
Tomasson, G., Grayson, P. C., Mahr, A. D., LaValley, M., & Merkel, P. A. (2012) · Rheumatology · doi:10.1093/rheumatology/ker280 · Cited by 353
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
Xiao, H., Dairaghi, D. J., Powers, J. P., Ertl, L. S., Baumgart, T., Wang, Y., Seitz, L. C., Penfold, M. E. T., Gan, L., Hu, P., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013020143 · Cited by 353
Self-citationANCA-associated vasculitis — clinical utility of using ANCA specificity to classify patients
Cornec, D., Gall, E. C.-L., Fervenza, F. C., & Specks, U. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.123 · Cited by 294
Gou, S., Yuan, J., Chen, M., Yu, F., & Zhao, M. (2012) · Kidney International · doi:10.1038/ki.2012.313 · Cited by 282
Little, M. A., Smyth, C. L., Yadav, R., Ambrose, L., Cook, H. T., Nourshargh, S., & Pusey, C. D. (2005) · Blood · doi:10.1182/blood-2005-03-0921 · Cited by 276
Pagnoux, C., Hogan, S. L., Chin, H., Jennette, J. C., Falk, R. J., Guillevin, L., & Nachman, P. H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23800 · Cited by 272
Self-citationWalsh, M., Casian, A., Flossmann, O., Westman, K., Höglund, P., Pusey, C., & Jayne, D. R. W. (2013) · Kidney International · doi:10.1038/ki.2013.131 · Cited by 264
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis
Roth, A. J., Ooi, J. D., Hess, J. J., van Timmeren, M. M., Berg, E. A., Poulton, C. E., McGregor, J., Burkart, M., Hogan, S. L., Hu, Y., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65292 · Cited by 259
Self-citationWalsh, M., Merkel, P. A., Peh, C. A., Szpirt, W., Guillevin, L., Pusey, C. D., deZoysa, J., Ives, N., Clark, W. F., Quillen, K., et al. (2013) · Trials · doi:10.1186/1745-6215-14-73 · Cited by 243
Walsh, M., Merkel, P. A., Mahr, A., & Jayne, D. (2010) · Arthritis Care & Research · doi:10.1002/acr.20176 · Cited by 241
Yates, M., & Watts, R. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-1-60 · Cited by 231
Neutrophil Extracellular Traps in ANCA-Associated Vasculitis
Söderberg, D., & Segelmark, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00256 · Cited by 210
Pendergraft, W. F., & Niles, J. L. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000014 · Cited by 183
Merkel, P. A., Xie, G., Monach, P. A., Ji, X., Ciavatta, D. J., Byun, J., Pinder, B. D., Zhao, A., Zhang, J., Tadesse, Y., et al. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40034 · Cited by 178
Savige, J., Dimech, W., Fritzler, M., Goeken, J., Hagen, E. C., Jennette, J. C., McEvoy, R., Pusey, C., Pollock, W., Trevisin, M., et al. (2003) · American Journal of Clinical Pathology · doi:10.1309/waepadw0k4lpuhfn · Cited by 164
Self-citationSavige, F., Dimech, F., Fritzler, M., Goeken, M., Hagen, M., Jennette, M., McEvoy, P., Pusey, M., Pollock, W., Trevisin, M., et al. (2003) · American Journal of Clinical Pathology · doi:10.1309/waep-adw0-k4lp-uhfn · Cited by 160
O’Sullivan, K. M., Lo, C. Y.-W., Summers, S. A., Elgass, K., McMillan, P. J., Longano, A., Ford, S. L., Gan, P., Kerr, P. G., Kitching, A. R., et al. (2015) · Kidney International · doi:10.1038/ki.2015.202 · Cited by 159
Heijl, C., Harper, L., Floßmann, O., Stücker, I., Scott, D., Watts, R. A., Höglund, P., Westman, K. W. A., & Mahr, A. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.145250 · Cited by 154
O'Shaughnessy, M. M., Hogan, S. L., Poulton, C. J., Falk, R. J., Singh, H. K., Nickeleit, V., & Jennette, J. C. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10871016 · Cited by 154
Self-citationPredictors of Treatment Outcomes in ANCA-Associated Vasculitis with Severe Kidney Failure
Lee, T., Gasim, A., Derebail, V. K., Chung, Y., McGregor, J. G., Lionaki, S., Poulton, C. J., Hogan, S. L., Jennette, J. C., Falk, R. J., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08290813 · Cited by 151
Self-citationMiloslavsky, E. M., Specks, U., Merkel, P. A., Seo, P., Spiera, R., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., Clair, E. W. S., Tchao, N. K., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38044 · Cited by 123
Decreased CD5+ B Cells in Active ANCA Vasculitis and Relapse after Rituximab
Bunch, D. O., McGregor, J. G., Khandoobhai, N. B., Aybar, L. T., Burkart, M., Hu, Y., Hogan, S. L., Poulton, C. J., Berg, E. A., Falk, R. J., et al. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03950412 · Cited by 103
Self-citationSanders, J., de Joode, A. A. E., DeSevaux, R. G., Broekroelofs, J., Voskuyl, A. E., van Paassen, P., Kallenberg, C. G. M., Tervaert, J. W. C., & Stegeman, C. A. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw211 · Cited by 67
Incidence and features of dual anti‐GBM‐positive and ANCA‐positive patients
de Zoysa, J., Taylor, D. M., THEIN, H., & Yehia, M. (2011) · Nephrology · doi:10.1111/j.1440-1797.2011.01484.x · Cited by 43
Gan, P., Holdsworth, S. R., Kitching, A. R., & Ooi, J. D. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.04.007 · Cited by 37
Schreiber, A., Eulenberg-Gustavus, C., Bergmann, A., Jerke, U., & Kettritz, R. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0116-037r · Cited by 19
Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans
Geetha, D., Poulton, C. J., Hu, Y., Seo, P., Mcgregor, J., Falk, R. J., & Hogan, S. L. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.11.011 · Cited by 9
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Kitching, A. R., Anders, H.-J., Basu, N., Brouwer, E., Gordon, J., Jayne, D. R., Kullman, J., Lyons, P. A., Merkel, P. A., Savage, C. O. S., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0204-y · Cited by 928
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study
Booth, A. D., Almond, M. K., Burns, A., Ellis, P., Gaskin, G., Neild, G. H., Plaisance, M., Pusey, C. D., & Jayne, D. R. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00025-8 · Cited by 504
Aging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Metadata
- Authors
- Jennette, J. C., & Nachman, P. H.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-08-25
- Volume
- 12
- Issue
- 10
- Pages
- 1680-1691
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- OpenAlex
- W2746848409
- Cited by
- 360
- References
- 47
- FWCI
- 21.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.